
Esi sikhokelo sibanzi siphonononga ubunzima bonyango lomhlaza wemiphunga e-China, sigxile kwizigulane ezinokuguqulwa kofuzo. Siphengulula kuphando lwamva nje, ukhetho lonyango, kunye nezixhobo ezifumanekayo ukunceda izigulana kunye neentsapho zazo ukuba zihambe kolu hambo lucelomngeni. Siza kuvavanya ukuxhaphaka kweenguqu ezithile, sixoxe ngonyango olujoliswe kuyo, kwaye sigxininise ukubaluleka kokufunyanwa kwangaphambili kunye neyeza lomntu ekuphuculeni iziphumo.
Umhlaza wemiphunga eTshayina, njengakwezinye iindawo zehlabathi, uhlala unxulunyaniswa notshintsho lwemfuza. Iinguqu ezininzi, ezifana ne-EGFR, ALK, ROS1, kunye ne-KRAS, zixhaphake zifunyenwe kwaye zinempembelelo enkulu kwiindlela zonyango. Ukuxhaphaka kolu tshintsho kunokwahluka ngokuxhomekeke kwizinto ezifana nembali yokutshaya kunye nobuhlanga. Ukuqonda uhlobo oluthile lwemfuzo yethumba kubalulekile ekulungiseni izicwangciso zonyango olusebenzayo. Uphando olongezelelekileyo kwimo yemfuza ye Umhlaza wemiphunga waseTshayina wokuguqula ufuzo iyaqhuba, inegalelo kwinkqubela phambili kunyango lomntu.
Izehlo kunye neentlobo zokuguqulwa kofuzo kwi Umhlaza wemiphunga waseTshayina wokuguqula ufuzo ingabonisa ukwahluka kwejografi ngaphakathi kweTshayina ngokwayo. Izinto ezisingqongileyo, ukhetho lwendlela yokuphila, kunye nokuvezwa kwe-carcinogens kunokuchaphazela ukuxhaphaka kweenguqu ezithile. Izifundo ezinzulu ze-epidemiological ziyaqhubeka nokucokisa ukuqonda kwethu ezi yantlukwano kunye neziphumo zazo kuthintelo kunye nezicwangciso zonyango. Ufikelelo kuvavanyo oluphambili lwe-genomic lubalulekile kuxilongo oluchanekileyo kunye nezicwangciso zonyango lomntu ngamnye.
Unyango ekujoliswe kulo luguqula unyango lwe Umhlaza wemiphunga waseTshayina wokuguqula ufuzo. Olu nyango lujolise ekuziphatheni okungaqhelekanga kwimfuza ngaphakathi kweeseli zomhlaza, ukunciphisa ingozi kwizihlunu eziphilileyo. Ngokomzekelo, i-EGFR tyrosine kinase inhibitors (TKIs) iyasebenza kakhulu kwizigulane ezinokuguqulwa kwe-EGFR. Ezinye iindlela zonyango ezijoliswe kuzo ziyafumaneka kwi-ALK, i-ROS1, kunye nolunye utshintsho lofuzo. Ukhetho lonyango olujoliswe kuyo luxhomekeke kwinguqu ethile echongiweyo ngovavanyo lwe-genomic.
I-Immunotherapy idlala indima ebalulekileyo ekunyangeni umhlaza wemiphunga, ngakumbi kwiimeko ezinotshintsho oluthile lwemfuzo. I-Immunotherapies isebenza ngokuvuselela amajoni omzimba ukuba ahlasele iiseli zomhlaza. Ukusebenza kwe-immunotherapy kunokuphenjelelwa yiprofayili yemfuza yethumba kunye nempilo yonke yesigulane. Ukudibanisa i-immunotherapy kunye nonyango olujoliswe kuyo yindlela ethembisayo.
Ngelixa iindlela zonyango ezijoliswe kuzo kunye ne-immunotherapy zisanda, iindlela zemveli ezinjengotyando, ichemotherapy, kunye nonyango lweradiation zisabambe indawo kunyango lwe. Umhlaza wemiphunga waseTshayina wokuguqula ufuzo, edla ngokusetyenziswa kunye neendlela ezintsha ngokuxhomekeke kwinqanaba lomhlaza kunye nempilo yomguli.
Ukuhamba ngenkqubo yokhathalelo lwempilo kunokuba ngumceli mngeni, ngakumbi xa ujongene nesifo esintsonkothileyo njengomhlaza wemiphunga. Izibhedlele ezininzi kunye namaziko ophando e-China aphambili kuphando lomhlaza kunye nonyango, kubandakanya IZiko loPhando ngoMhlaza laseShandong Baofa. Izigulane kufuneka ziqhagamshelane ne-oncologist yazo ukuze zibone isicwangciso sonyango esifanelekileyo ngokusekelwe kwiimfuno zabo kunye neemeko zabo. Amaqela enkxaso kunye nemibutho exhasa izigulane zinokubonelela ngoncedo oluxabisekileyo ngokwasemoyeni nolwenziwayo.
Uphando kwi Umhlaza wemiphunga waseTshayina wokuguqula ufuzo unyango luyaqhubeka, kugxilwe ekuchongeni iithagethi zonyango olutsha, ukuphucula unyango olusele lukhona, kunye nokuphuhlisa iindlela zonyango zomntu. Ulingo lwezonyango lwenziwa rhoqo e-China lunikezela ukufikelela kunyango oluphambili. Ukufunyaniswa kwangethuba kuhlala kubalulekile ekuphuculeni iziphumo. Uphando oluqhubekayo luya kudlala indima ebalulekileyo ekuphuculeni ubomi babantu abachatshazelwe sesi sifo.
| Uhlobo loNyango | Iingenelo | Iingxaki |
|---|---|---|
| Unyango ekujoliswe kulo | Okucacileyo kakhulu, iziphumo ebezingalindelekanga ezimbalwa kunechemotherapy | Isenokungasebenzi kuzo zonke iinguqu, ezinokubakho zokunganyangeki ngamachiza |
| Immunotherapy | Iziphumo ezihlala ixesha elide, zinokujolisa kwiiseli ezininzi zomhlaza | Inokubangela iziphumo ebezingalindelekanga ezibalulekileyo, zinokungasebenzi kuzo zonke izigulane |
I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Soloko udibana nengcali yokhathalelo lwempilo olufanelekileyo ukuze uxilongwe kunye nonyango lwaso nasiphi na isimo sonyango.
Imithombo: (Bandakanya izicatshulwa ezifanelekileyo apha, ukubhekisela kwizifundo ezithile kunye neewebhusayithi ezisemthethweni ezinxulumene nonyango lomhlaza wemiphunga e-China, umzekelo, i-National Cancer Institute, iijenali zonyango zaseTshayina, njl.)
ecaleni>
umzimba>